NewAmsterdam Pharma
NAMS
NAMS
130 hedge funds and large institutions have $2.53B invested in NewAmsterdam Pharma in 2024 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 31 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% more funds holding
Funds holding: 100 → 130 (+30)
8.73% more ownership
Funds ownership: 85.64% → 94.37% (+8.7%)
35% less call options, than puts
Call options by funds: $8.11M | Put options by funds: $12.6M
Holders
130
Holding in Top 10
8
Calls
$8.11M
Puts
$12.6M
Top Buyers
| 1 | +$87.7M | |
| 2 | +$78.7M | |
| 3 | +$76.5M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.1M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$53M |
Top Sellers
| 1 | -$31.7M | |
| 2 | -$26.9M | |
| 3 | -$25.3M | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$14M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$13.8M |